S3V Vascular Technologies Unlisted Shares
S3V Vascular Technologies – Indigenous Stroke Care Device Manufacturing
Money Control
2 min read
Expert Analysis:
S3V Vascular Technologies, backed by the Technology Development Board, will establish India's first integrated facility for indigenous mechanical thrombectomy devices near Sriperumbudur, Tamil Nadu, producing microcatheters, guidewires, aspiration catheters, and stent retrievers to address India's USD 2 billion neuro-intervention market.
The venture has attracted institutional and investor backing from L&T Chairman Emeritus A.M. Naik, Madhusudan Kela (MK Ventures), and Utpal Sheth (Rare Enterprises), signaling confidence in the medical device import-substitution opportunity and domestic healthcare manufacturing scaling.
S3V's strategy includes proprietary innovations (clot retriever head, braid-over-coil aspiration catheter), CE/USFDA certifications for exports, and partnerships with Ayushman Bharat and hospitals to expand affordable access in Tier-II and rural regions via simulator-based training and public health integration.
Key Takeaway:
S3V's govt-backed initiative to indigenize stroke-care devices addresses a critical import-substitution gap in India's high-end medical device sector, though scaling production, regulatory clearances, and clinical adoption remain key execution risks in a historically multinational-dominated category.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved